The methanolic crude extract of D. esculentum inhibited AChE activities in vitro, with half-maximal inhibitory concentration (IC50) value at 272.97 ± 19.38 μg/mL, implying that it might be a promising candidate for prevention or treatment of AD by supporting cholinergic neurons17. Here, ACHE is linked to Alzheimer disease.